LS 174T In Vitro Colony Formation Assay (Cell Proliferation)
CAT#: ITS-1122-YF339
Target Cell Organism: Human
Target Cell Name: LS 174T
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide LS 174T-based In Vitro Colony Formation Assay (Cell Proliferation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LS 174T
Target Cell Organism
Human
Target Cell Background
LS 174T is a cell exhibiting epithelial morphology that was isolated from the colon of a White, 58-year-old, female adenocarcinoma patient with colorectal cancer. This cell line was deposited by Northwestern University and can be used in cancer research.
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Colony Formation Assay (Cell Proliferation)
Short Description
LS 174T-cell based In Vitro Colony Formation Assay (Cell Proliferation)
Assay Description
Colony formation assay is one of the widely used assays based on the ability of cancer cells to form into colonies. This assay is useful to determine the effects of a drug or external stimuli such as radiation on clonogenic growth of cancer cells. This can be easily carried out for any type of cancer cells grown as a monolayer or as non-adherent cells. Before starting cell seeding, all the cells to be plated must be properly detached to avoid colonies at the starting point. A colony must contain a minimum of 50 cells and formed colonies are counted after staining with a suitable dye such as trypan blue. A microscope is usually used to visualize cell colonies and counting is normally carried out manually.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.